MYELOID THERAPEUTICS

Myeloid is powered by the discoveries of our founders - a group of world-leading scientists whose expertise spans oncology, immunology, mRNA biology, cell therapy, synthetic biology, and gene delivery... At Myeloid, we have applied our extensive knowledge of advanced gene and cell therapies to build novel platform technologies and unleash the power of myeloid cells in cancer... Integrating the fields of RNA, immunology and medicine, our proprietary platform provides clinical solutions by matching therapeutic modalities to disease conditions, including by using autologous cell therapies, in vivo cell programming using mRNA, RNA-based gene-editing using RetroT™ and multi-targeted biologics

Also known as: Myeloid, Myeloid Therapeutics, Inc.

Primary location: Cambridge United States